FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014350037> ?p ?o ?g. }

• W2014350037 endingPage "118" @default.
• W2014350037 startingPage "109" @default.
• W2014350037 abstract "The preclinical safety studies required to support the development of inhaled drugs are generally the same as for other routes of administration. Repeat-dose toxicology studies should be conducted by inhalation to ensure the characterization of both the local (i.e., respiratory) and systemic toxicity, although some studies (e.g., reproductive) can be performed by utilizing alternative routes, when it is paramount to maximize systemic exposure. Respiratory tract changes in preclinical species can include irritancy of the larynx and nasal cavity, particularly in rodents. Such changes are not necessarily predictive of a risk to humans because of the exquisite sensitivity of the rodent larynx and the lack of exposure to the nasal cavity after oro-inhalation of drugs in the clinical setting. The design of poorly soluble molecules to limit systemic exposure places greater emphasis on the elimination of drugs from the lungs by macrophages. Consequently, an increase in macrophage numbers is often noted, and in the absence of any other changes, this is generally considered to be a nonadverse, physiological response to an inhaled particulate. Other changes in the lung, which can include an inflammatory response and/or epithelial hyperplasia, resulting from irritancy or particulate overload, are a safety concern and are not monitorable in humans. For such changes, safety margins can be calculated in terms of the drug deposited per unit weight of lung. These factors should be taken into account when designing preclinical studies or programs for inhaled drugs." @default.
• W2014350037 created "2016-06-24" @default.
• W2014350037 creator A5000543104 @default.
• W2014350037 date "2012-01-25" @default.
• W2014350037 modified "2023-09-25" @default.
• W2014350037 title "Regulatory toxicology considerations for the development of inhaled pharmaceuticals" @default.
• W2014350037 cites W159350064 @default.
• W2014350037 cites W1964143795 @default.
• W2014350037 cites W1967620942 @default.
• W2014350037 cites W1969960152 @default.
• W2014350037 cites W1970264991 @default.
• W2014350037 cites W1972305107 @default.
• W2014350037 cites W1978045341 @default.
• W2014350037 cites W1983251458 @default.
• W2014350037 cites W1988888066 @default.
• W2014350037 cites W1991335253 @default.
• W2014350037 cites W1996838083 @default.
• W2014350037 cites W2005216394 @default.
• W2014350037 cites W2007183298 @default.
• W2014350037 cites W2010566912 @default.
• W2014350037 cites W2017749879 @default.
• W2014350037 cites W2023920135 @default.
• W2014350037 cites W2029720457 @default.
• W2014350037 cites W2032256656 @default.
• W2014350037 cites W2037714073 @default.
• W2014350037 cites W2039427369 @default.
• W2014350037 cites W2041548960 @default.
• W2014350037 cites W2047849448 @default.
• W2014350037 cites W2052851260 @default.
• W2014350037 cites W2057682847 @default.
• W2014350037 cites W2063320086 @default.
• W2014350037 cites W2063943133 @default.
• W2014350037 cites W2068759261 @default.
• W2014350037 cites W2078283988 @default.
• W2014350037 cites W2083259678 @default.
• W2014350037 cites W2085530326 @default.
• W2014350037 cites W2086220988 @default.
• W2014350037 cites W2089160980 @default.
• W2014350037 cites W2109895097 @default.
• W2014350037 cites W2120166044 @default.
• W2014350037 cites W2121692565 @default.
• W2014350037 cites W2136691990 @default.
• W2014350037 cites W2141332354 @default.
• W2014350037 cites W2151507869 @default.
• W2014350037 cites W2152582355 @default.
• W2014350037 cites W2163824979 @default.
• W2014350037 cites W2168094174 @default.
• W2014350037 cites W2171699064 @default.
• W2014350037 cites W2211226383 @default.
• W2014350037 cites W2482561613 @default.
• W2014350037 cites W2498244338 @default.
• W2014350037 cites W2605466593 @default.
• W2014350037 cites W3021212514 @default.
• W2014350037 cites W3026667644 @default.
• W2014350037 cites W4240493087 @default.
• W2014350037 cites W4245955583 @default.
• W2014350037 doi "https://doi.org/10.3109/01480545.2011.648327" @default.
• W2014350037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22273711" @default.
• W2014350037 hasPublicationYear "2012" @default.
• W2014350037 type Work @default.
• W2014350037 sameAs 2014350037 @default.
• W2014350037 citedByCount "21" @default.
• W2014350037 countsByYear W20143500372013 @default.
• W2014350037 countsByYear W20143500372014 @default.
• W2014350037 countsByYear W20143500372015 @default.
• W2014350037 countsByYear W20143500372017 @default.
• W2014350037 countsByYear W20143500372018 @default.
• W2014350037 countsByYear W20143500372019 @default.
• W2014350037 countsByYear W20143500372020 @default.
• W2014350037 countsByYear W20143500372021 @default.
• W2014350037 countsByYear W20143500372022 @default.
• W2014350037 crossrefType "journal-article" @default.
• W2014350037 hasAuthorship W2014350037A5000543104 @default.
• W2014350037 hasConcept C126322002 @default.
• W2014350037 hasConcept C141071460 @default.
• W2014350037 hasConcept C2776954882 @default.
• W2014350037 hasConcept C2777714996 @default.
• W2014350037 hasConcept C2779644171 @default.
• W2014350037 hasConcept C2779777708 @default.
• W2014350037 hasConcept C2780035454 @default.
• W2014350037 hasConcept C2780474809 @default.
• W2014350037 hasConcept C29730261 @default.
• W2014350037 hasConcept C33070731 @default.
• W2014350037 hasConcept C42219234 @default.
• W2014350037 hasConcept C534529494 @default.
• W2014350037 hasConcept C71924100 @default.
• W2014350037 hasConcept C86803240 @default.
• W2014350037 hasConcept C98274493 @default.
• W2014350037 hasConceptScore W2014350037C126322002 @default.
• W2014350037 hasConceptScore W2014350037C141071460 @default.
• W2014350037 hasConceptScore W2014350037C2776954882 @default.
• W2014350037 hasConceptScore W2014350037C2777714996 @default.
• W2014350037 hasConceptScore W2014350037C2779644171 @default.
• W2014350037 hasConceptScore W2014350037C2779777708 @default.
• W2014350037 hasConceptScore W2014350037C2780035454 @default.
• W2014350037 hasConceptScore W2014350037C2780474809 @default.
• W2014350037 hasConceptScore W2014350037C29730261 @default.
• W2014350037 hasConceptScore W2014350037C33070731 @default.

• next